New protein powders could make life easier for people with rare metabolic disorders
NCT ID NCT06941532
First seen Jan 03, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This study is testing four new powdered protein substitutes for people with phenylketonuria (PKU) or tyrosinemia (TYR). These products are designed to be more palatable and easier to tolerate than current options, potentially improving diet compliance. The study will enroll 40 adults and children over age 3 across UK metabolic centers, monitoring gastrointestinal tolerance, acceptability, and safety over 29 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Birmingham Women and Children's Hospital
RECRUITINGBirmingham, United Kingdom
Conditions
Explore the condition pages connected to this study.